Leslie Rutledge, Attorney General of Arkansas, Petitioner, v. Pharmaceutical Care Management Association
Case Number:
18-540
Court:
Nature of Suit:
4950 Constitutionality of State Statutes
Firms
- Alexander Dubose
- Duane Morris
- Foley Hoag
- Frier Levitt
- Jenner & Block
- Katten Muchin
- McAfee & Taft
- Miller & Chevalier
- Seyfarth Shaw
- Sidley Austin
- Sullivan & Cromwell
- Weisbrod Matteis
- WilmerHale
Companies
- AARP Inc.
- Academy of Managed Care Pharmacy
- AIDS Healthcare Foundation
- American Medical Association Inc.
- America's Health Insurance Plans Inc.
- J.B. Hunt Transport Services Inc.
- National Association of Chain Drug Stores
- Pharmaceutical Care Management Association
Sectors & Industries:
-
February 19, 2021
High Court Ruling May Be A Boon For Benefits Access
A recent U.S. Supreme Court ruling narrowing the scope of ERISA's preemption clause will likely clear the way for more cities and states to require employers to boost workers' access to health care and retirement programs, experts say.
-
February 05, 2021
High Court ERISA Ruling Frees States To Tackle Health Costs
The U.S. Supreme Court's recent holding that Arkansas can regulate the middlemen that control employee health plans' prescriptions without treading on ERISA's territory opens the door for states to take more aggressive action to reduce health care costs, experts say.
-
January 03, 2021
ERISA Arbitration, New Legal Theories To Be Tested In 2021
In 2021, courts stand poised to consider whether employers can kick benefit plan mismanagement suits to arbitration and whether two novel theories in class actions over retirement plans hold water. Here, Law360 highlights six ERISA cases to watch in the new year.
-
December 10, 2020
High Court Gives States Green Light To Regulate PBMs
The U.S. Supreme Court backed an Arkansas law Thursday that bans insurers' affiliates from shortchanging pharmacies, clearing the way for other states to regulate pharmacy benefit managers and throwing a lifeline to small pharmacies that said PBMs' business practices were bankrupting them.
-
October 13, 2020
High Court PBM Case Could Be Turning Point In 20-Year Fight
Last week's U.S. Supreme Court arguments over Arkansas' attempt to regulate how much middlemen called pharmacy benefit managers reimburse pharmacies for drugs on insurers' behalf could mark a turning point in a broader legal fight that's been playing out for 20 years.
-
October 06, 2020
Justices Eye Arkansas PBM Law's Impact On Workers
The U.S. Supreme Court on Tuesday focused on whether an Arkansas law's potential costliness to employee benefit plans is enough to place it in conflict with the Employee Retirement Income Security Act, with two conservative justices questioning whether the statute regulating pharmacy benefit managers would end up hurting workers.
-
October 05, 2020
High Court To Weigh States' Ability To Rein In Drug Middlemen
The U.S. Supreme Court will hear arguments Tuesday over whether states can control the rates at which local pharmacies get reimbursed for drugs by health insurance plans, a case that could determine whether states can regulate pharmacy benefit managers without getting waylaid by federal benefits law.
-
July 29, 2020
5 ERISA Cases To Watch In The 2nd Half Of 2020
From a U.S. Supreme Court case over an Arkansas law regulating pharmacy benefit managers' drug reimbursement rates to a new suit challenging UnitedHealth Group's "cross-plan offsetting" method of recouping overpayments, the second half of 2020 is gearing up to be interesting. Here, Law360 looks at five ERISA cases lawyers should keep an eye on.
-
April 27, 2020
ERISA Doesn't Trump Drug Benefit Law, Ark. Tells High Court
Arkansas has urged the U.S. Supreme Court to undo the Eighth Circuit's finding that a state law regulating pharmacy benefits managers is trumped by ERISA, saying the trade group challenging the law made arguments that defied common sense and rang hollow.
-
April 16, 2020
High Court Delays Arguments In Birth Control, PBM Cases
Since the coronavirus pandemic canceled the U.S. Supreme Court's April term, the high court has been gradually rescheduling the arguments it had planned to hear over the next few weeks — including those in two high-profile benefits and health care law cases.